Literature DB >> 7685385

Ion channel involvement in the acute vascular effects of thiazide diuretics and related compounds.

J A Calder1, M Schachter, P S Sever.   

Abstract

The involvement of calcium and potassium channels in mediating the vascular actions of hydrochlorothiazide, indapamide and cicletanine were investigated in guinea pig small vessels mounted on the Mulvany myograph. Hydrochlorothiazide (10 microM) and cicletanine (10 microM) were weak calcium antagonists shifting the calcium dose-response curve half a log unit to the right. Indapamide was a far more potent inhibitor, a 10 microM concentration shifting the calcium dose-response curve 3 log units to the right and reducing maximal calcium contraction by 72% (P < .001). Relaxations to hydrochlorothiazide and cicletanine were reduced in the presence of charybdotoxin, a blocker of calcium-activated potassium channels (KCa). Maximal relaxation induced by hydrochlorothiazide (30 microM) was reduced by 91% and cicletanine-induced relaxation by 63%. In the presence of iberiotoxin, a more selective KCa inhibitor, maximal hydrochlorothiazide and cicletanine-induced relaxations were reduced by 73 and 60%, respectively. Neither drug's action was affected by incubation with glibenclamide, which inhibits ATP-sensitive K+ channels. Incubation with glibenclamide, charybdotoxin or iberiotoxin had no effect on the indapamide-induced relaxation. These results show differences in the involvement of ion channels in the acute vasorelaxation produced by these drugs. Hydrochlorothiazide and cicletanine-induced relaxations appear to be mediated via KCa, whereas indapamide is a potent calcium antagonist.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685385

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension.

Authors:  C S Ceron; M M Castro; E Rizzi; M F Montenegro; V Fontana; M C O Salgado; R F Gerlach; J E Tanus-Santos
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

2.  Activation of human smooth muscle BK channels by hydrochlorothiazide requires cell integrity and the presence of BK β1 subunit.

Authors:  Pedro Martín; Melisa Moncada; Guruprasad Kuntamallappanavar; Alex M Dopico; Verónica Milesi
Journal:  Acta Pharmacol Sin       Date:  2017-11-30       Impact factor: 6.150

3.  Lack of thiazide diuretic inhibition of agonist constriction of mouse mesenteric arterioles ex vivo.

Authors:  Robert M Rapoport; Amanda J LeBlanc; Jason E Beare; Manoocher Soleimani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-23       Impact factor: 3.000

Review 4.  New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases.

Authors:  Erik R Swenson
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

5.  Role of EDHF in the vasodilatory effect of loop diuretics in guinea-pig mesenteric resistance arteries.

Authors:  F Pourageaud; C Bappel-Gozalbes; R Marthan; J L Freslon
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

6.  Relaxation and decrease in [Ca2+]i by hydrochlorothiazide in guinea-pig isolated mesenteric arteries.

Authors:  P Pickkers; A D Hughes
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

Review 7.  Delapril plus indapamide: a review of the combination in the treatment of hypertension.

Authors:  Luca Cavalieri; Giovanni Cremonesi
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

8.  Multicomponent intervention versus usual care for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: study protocol for a cluster randomized controlled trial.

Authors:  Tazeen H Jafar; Imtiaz Jehan; H Asita de Silva; Aliya Naheed; Mihir Gandhi; Pryseley Assam; Eric A Finkelstein; Helena Legido Quigley; Marcel Bilger; Aamir Hameed Khan; John David Clemens; Shah Ebrahim; Elizabeth L Turner; Anuradhani Kasturiratne
Journal:  Trials       Date:  2017-06-12       Impact factor: 2.279

Review 9.  Beyond the usual strategies for blood pressure reduction: therapeutic considerations and combination therapies.

Authors:  T D Giles; G E Sander
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Nov-Dec       Impact factor: 3.738

10.  Hydrochlorothiazide Potentiates Contractile Activity of Mouse Cavernosal Smooth Muscle.

Authors:  Thiago Gagliano-Jucá; Mauro Napolitano; Fernanda Del Grossi Ferraz Carvalho; Rafael Campos; Fabíola Zakia Mónica; Mário Angelo Claudino; Edson Antunes; Anibal Gil Lopes; Gilberto De Nucci
Journal:  Sex Med       Date:  2016-03-19       Impact factor: 2.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.